Endogenously formed nitric oxide modulates cell growth in bladder cancer cell lines.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Urology

• Publication date

  1999-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0090-4295(99)00033-3PMID 10367864
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of nitric oxide in bacillus Calmette-Guérin mediated anti-tumour effects in human bladder cancer.

  1998cited by this paper
• Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.

  1997cited by this paper
• Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter.

  1996cited by this paper
• Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo.

  1996cited by this paper
• Roles of nitric oxide in tumor growth.

  1995cited by this paper
• Changes in urinary cytokines and soluble intercellular adhesion molecule‐1 (ICAM‐1) in bladder cancer patients after Bacillus Calmette—Guérin (BCG) immunotherapy

  1995cited by this paper
• Molecular mechanisms and therapeutic strategies related to nitric oxide

  1995cited by this paper
• Uptake of nitric oxide synthase inhibitors by macrophage RAW 264.7 cells.

  1994cited by this paper
• Nitric oxide synthases in mammals.

  1994cited by this paper
• Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms.

  1994cited by this paper
• Nitric oxide is an important mediator for tumoricidal activity in vivo.

  1994cited by this paper
• Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation.

  1994cited by this paper
• Nitric oxide synthase activity in human gynecological cancer.

  1994cited by this paper
• Optimal BCG treatment of superficial bladder cancer as defined by American trials.

  1992cited by this paper
• Widespread tissue distribution, species distribution and changes in activity of Ca2+‐dependent and Ca2+‐independent nitric oxide synthases

  1991cited by this paper
• Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets.

  1991cited by this paper
• Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: A molecular mechanism regulating cellular proliferation that targets intracellular iron

  1990cited by this paper
• Urinary interleukins in patients receiving intravesical bacillus calmette‐guerin therapy for superficial bladder cancer

  1989cited by this paper
• Interleukin-2 production during intravesical bacille Calmette-Guerin therapy for bladder cancer.

  1986cited by this paper
• Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes

  1977cited by this paper
• Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors.

  1976cited by this paper

• Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy

  2022cites this paper
• Oxidative stress parameters as biomarkers of bladder cancer development and progression

  2021cites this paper
• Bladder Pain Syndrome/Interstitial Cystitis

  2020cites this paper
• Effects of BCG-treatment on urinary bladder cancer with focus on nitric oxide

  2019cites this paper
• Inflammatory microenvironment in the initiation and progression of bladder cancer

  2017cites this paper
• The Discovery and Development of Drug Combinations for the Treatment of Various Diseases from Patent Literature (1980-Present).

  2017cites this paper
• Bladder Cancer and NOS-NO Gene Polymorphısms

  2015cites this paper
• Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes

  2015cites this paper
• Bladder Cancer and NOS-NO Gene Polymorphisms

  2015cites this paper
• Secondary stimulation from Bacillus Calmette-Guérin induced macrophages induce nitric oxide independent cell-death in bladder cancer cells.

  2014cites this paper
• A cancer vaccine based on the marine antimicrobial peptide pardaxin (GE33) for control of bladder-associated tumors.

  2013cites this paper
• Nitric oxide synthase (eNOS4a/b) gene polymorphism is associated with tumor recurrence and progression in superficial bladder cancer cases.

  2012cites this paper
• Localization and expression of inducible nitric oxide synthase in patients after BCG treatment for bladder cancer.

  2012cites this paper
• Bladder pain syndrome/interstitial cystitis. Studies on classic BPS/IC, ESSIC type 3C, with special reference to the role of nitric oxide

  2012cites this paper
• On the role of nitric oxide in lower urinary tract disease

  2011cites this paper
• The (CCTTT)n microsatellite polymorphism in the nitric oxide synthase 2 gene may influence bladder cancer pathogenesis.

  2010cites this paper
• Mycobacterium bovis Bacillus Calmette-Guérin-Induced Macrophage Cytotoxicity against Bladder Cancer Cells

  2010cites this paper
• Nitric oxide regulates neurogenesis in adult olfactory epithelium in vitro.

  2009cites this paper
• Association Between Positive iNOS mRNA Expression and Recurrence-free Survival Among Patients with Non-muscle-invasive Bladder Cancer

  2008cites this paper
• Dynamic Thermal Assessment

  2007cites this paper
• Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines

  2007cites this paper
• Can the levels of nitric oxide in the urine, serum and tumor tissue be putative markers for bladder cancer?

  2006cites this paper
• Enhanced formation of nitric oxide in bladder carcinoma in situ and in BCG treated bladder cancer.

  2006cites this paper
• Measurement of nitric oxide may differentiate between inflammatory and non-inflammatory prostatitis

  2006influential citation
• Novel insights into the mechanism of action of intravesical immunomodulators.

  2005cites this paper
• The effect of intravesical Bacillus Calmette-Guerin instillations on the expression of inducible nitric oxide synthase in humans.

  2005cites this paper
• Antibacterial effects of nitrite in urine

  2005cites this paper
• Changes in end products of nitric oxide in urine and induction of nitric oxide synthase expression in urinary bladder during intravesical instillations of IFN-alpha2b.

  2004cites this paper
• Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines.

  2004cites this paper
• Relation between bladder cancer and protein oxidation

  2004cites this paper
• Changes in End Products of Nitric Oxide in Urine and Induction of Nitric Oxide Synthase Expression in Urinary Bladder During Intravesical Instillations of IFN-α2b

  2004cites this paper
• Increased Resistance to Nitric Oxide Cytotoxicity Associated with Differentiation of Neuroblastoma-Glioma Hybrid (NG108-15) Cells

  2002cites this paper
• Human renal epithelial cells express iNOS in response to cytokines but not bacteria.

  2002cites this paper
• N-acetylcysteine augments the cellular redox changes and cytotoxic activity of internalized mycobacterium bovis in human bladder cancer cells.

  2002cites this paper
• Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer.

  2001cites this paper
• Bacillus Calmette-Guerin induces long-term local formation of nitric oxide in the bladder via the induction of nitric oxide synthase activity in urothelial cells.

  2001cites this paper
• Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.

  2001cites this paper
• Matrix Metalloproteinase 2 in Tumor Cell-induced Platelet Aggregation : Regulation by Nitric Oxide 1

  2000cites this paper
• Critical Evaluation of ECV304 as a Human Endothelial Cell Model Defined by Genetic Analysis and Functional Responses: A Comparison with the Human Bladder Cancer Derived Epithelial Cell Line T24/83

  2000cites this paper
• Voiding dysfunction and female urology

  1997cites this paper